|
|
Last Modified: 8/20/2007  First Published: 6/23/2003 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II, Phase I
|
|
|
|
Prevention
|
|
|
|
Completed
|
|
|
|
18 and over
|
|
|
|
NCI
|
|
|
|
MDA-ID-00193 NCI-6053, NCT00064103, 6053
|
|
|
|
|
|
|
|
Last Modified: 7/1/1999  First Published: 5/1/1998 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
18 and over
|
|
|
|
Pharmaceutical / Industry
|
|
|
|
RP-T-201 SCCC-97050, NCI-V98-1393
|
|
|
|
|
|
|
|
Last Modified: 4/1/2000  First Published: 9/1/1998 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
18 and over
|
|
|
|
Pharmaceutical / Industry
|
|
|
|
AVENTIS-T-202 MCC-11653, RP-T-202, NCI-V98-1394, NCT00003257
|
|
|
|
|
|
|
|
Last Modified: 1/18/2008  First Published: 6/1/2001 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
18 and over
|
|
|
|
NCI
|
|
|
|
SWOG-S0011 S0011, NCT00017173
|
|
|
|
|
|
|
|
Last Modified: 7/19/2004  First Published: 9/1/2002 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II
|
|
|
|
Treatment
|
|
|
|
Completed
|
|
|
|
18 and over
|
|
|
|
Pharmaceutical / Industry
|
|
|
|
INTROGEN-201-010 MDA-ID-00008, NCT00044993
|
|
|
|
|
|
|
|
Last Modified: 5/1/2000  First Published: 1/1/1998 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase I
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
Over 18
|
|
|
|
NCI
|
|
|
|
PCI-96-035 NCI-T96-0059, NCT00003147, T96-0059
|
|
|
|
|
|
|
|
Last Modified: 12/1/2002  First Published: 2/1/1998 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase I
|
|
|
|
Treatment
|
|
|
|
Completed
|
|
|
|
18 and over
|
|
|
|
NCI
|
|
|
|
MDA-DM-96172 NCI-T96-0073, NCT00003167, T96-0073
|
|
|
|
|
|
|
|
Last Modified: 6/1/2001  First Published: 9/1/1998 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase I
|
|
|
|
Treatment
|
|
|
|
Completed
|
|
|
|
Over 18
|
|
|
|
NCI
|
|
|
|
FCCC-97009 NCI-T97-0042, NCT00004038, T97-0042
|
|
|
|
|
|
|
|
Last Modified: 6/1/2002  First Published: 9/1/1998 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase I
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
18 and over
|
|
|
|
NCI
|
|
|
|
UTSMC-089733300 NCI-T97-0096, NCT00003450, T97-0096
|
|
|
|
|
|
|
|
Last Modified: 6/1/2002  First Published: 11/1/1998 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase I
|
|
|
|
Treatment
|
|
|
|
Completed
|
|
|
|
18 and over
|
|
|
|
NCI
|
|
|
|
MDA-ID-97228 NCI-T97-0111, NCT00003588, T97-0111
|
|
|
|